INSMED INC Amortization of Intangible Assets
INSMED INC (INSM) reported Amortization of Intangible Assets of $2.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- INSMED INC amortization of intangible assets for the quarter ending 2026-06-30 was $2.08M, a 64.77% increase year-over-year.
- INSMED INC amortization of intangible assets for the quarter ending 2026-03-31 was $2.08M, a 64.77% increase year-over-year.
- INSMED INC amortization of intangible assets for the quarter ending 2025-12-31 was $1.94M, a 53.37% increase year-over-year.
- INSMED INC amortization of intangible assets for the quarter ending 2025-09-30 was $1.54M, a 21.77% increase year-over-year.
- INSMED INC amortization of intangible assets for fiscal 2025 was $6.00M, a 18.78% increase from fiscal 2024.
- INSMED INC amortization of intangible assets for fiscal 2024 was $5.05M, a 0.00% change from fiscal 2023.
- INSMED INC amortization of intangible assets for fiscal 2023 was $5.05M, a 0.02% decline from fiscal 2022.
- INSMED INC amortization of intangible assets for fiscal 2022 was $5.05M, a 0.02% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.08M 10-Q · filed 2026-08-06 | $4.16M 10-Q · filed 2026-08-06 | $6.10M derived: sum of 3 quarters · filed 2026-08-06 | $7.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.08M 10-Q · filed 2026-05-07 | $4.02M derived: sum of 2 quarters · filed 2026-05-07 | $5.56M derived: sum of 3 quarters · filed 2026-05-07 | $6.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.48M derived: sum of 2 quarters · filed 2026-02-19 | $4.74M derived: sum of 3 quarters · filed 2026-08-06 | $6.00M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.54M 10-Q · filed 2025-10-30 | $2.80M derived: sum of 2 quarters · filed 2026-08-06 | $4.06M 10-Q · filed 2025-10-30 | $5.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.26M 10-Q · filed 2026-08-06 | $2.53M 10-Q · filed 2026-08-06 | $3.79M derived: sum of 3 quarters · filed 2026-08-06 | $5.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.26M 10-Q · filed 2026-05-07 | $2.53M derived: sum of 2 quarters · filed 2026-05-07 | $3.79M derived: sum of 3 quarters · filed 2026-05-07 | $5.05M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.53M derived: sum of 2 quarters · filed 2026-02-19 | $3.79M derived: sum of 3 quarters · filed 2026-02-19 | $5.05M 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.26M 10-Q · filed 2025-10-30 | $2.53M derived: sum of 2 quarters · filed 2025-10-30 | $3.79M 10-Q · filed 2025-10-30 | $5.05M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.26M 10-Q · filed 2025-08-07 | $2.53M 10-Q · filed 2025-08-07 | $3.79M derived: sum of 3 quarters · filed 2026-02-19 | $5.05M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.26M 10-Q · filed 2025-05-08 | $2.53M derived: sum of 2 quarters · filed 2026-02-19 | $3.79M derived: sum of 3 quarters · filed 2026-02-19 | $5.05M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.53M derived: sum of 2 quarters · filed 2026-02-19 | $3.79M derived: sum of 3 quarters · filed 2026-02-19 | $5.05M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.26M 10-Q · filed 2024-10-31 | $2.53M derived: sum of 2 quarters · filed 2024-10-31 | $3.79M 10-Q · filed 2024-10-31 | $5.05M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $1.26M 10-Q · filed 2024-08-08 | $2.53M 10-Q · filed 2024-08-08 | $3.79M derived: sum of 3 quarters · filed 2025-02-20 | $5.05M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.26M 10-Q · filed 2024-05-09 | $2.53M derived: sum of 2 quarters · filed 2025-02-20 | $3.79M derived: sum of 3 quarters · filed 2025-02-20 | $5.05M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.53M derived: sum of 2 quarters · filed 2025-02-20 | $3.79M derived: sum of 3 quarters · filed 2025-02-20 | $5.05M 10-K · filed 2025-02-20 |
| 2022-09-30 | $1.26M 10-Q · filed 2023-10-26 | $2.53M derived: sum of 2 quarters · filed 2023-10-26 | $3.79M 10-Q · filed 2023-10-26 | $5.05M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.26M 10-Q · filed 2023-08-03 | $2.53M 10-Q · filed 2023-08-03 | $3.79M derived: sum of 3 quarters · filed 2024-02-22 | $5.05M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-04 | $2.52M derived: sum of 2 quarters · filed 2024-02-22 | $3.79M derived: sum of 3 quarters · filed 2024-02-22 | $5.05M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.53M derived: sum of 2 quarters · filed 2024-02-22 | $3.79M derived: sum of 3 quarters · filed 2024-02-22 | $5.05M 10-K · filed 2024-02-22 |
| 2021-09-30 | $1.26M 10-Q · filed 2022-10-27 | $2.53M derived: sum of 2 quarters · filed 2022-10-27 | $3.79M 10-Q · filed 2022-10-27 | $5.05M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.26M 10-Q · filed 2022-08-04 | $2.53M 10-Q · filed 2022-08-04 | $3.78M derived: sum of 3 quarters · filed 2023-02-23 | $5.03M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.26M 10-Q · filed 2022-05-05 | $2.52M derived: sum of 2 quarters · filed 2023-02-23 | $3.77M derived: sum of 3 quarters · filed 2023-02-23 | $5.02M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.51M derived: sum of 2 quarters · filed 2023-02-23 | $3.75M derived: sum of 3 quarters · filed 2023-02-23 | $5.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.25M 10-Q · filed 2021-10-28 | $2.50M derived: sum of 2 quarters · filed 2021-10-28 | $3.75M 10-Q · filed 2021-10-28 | $4.99M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $1.25M 10-Q · filed 2021-08-05 | $2.50M 10-Q · filed 2021-08-05 | $3.75M derived: sum of 3 quarters · filed 2022-02-17 | $4.99M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $1.25M 10-Q · filed 2021-05-06 | $2.50M derived: sum of 2 quarters · filed 2022-02-17 | $3.75M derived: sum of 3 quarters · filed 2022-02-17 | $4.99M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $2.50M derived: sum of 2 quarters · filed 2022-02-17 | $3.75M derived: sum of 3 quarters · filed 2022-02-17 | $4.99M 10-K · filed 2022-02-17 |
| 2019-09-30 | $1.25M 10-Q · filed 2020-10-29 | $2.50M derived: sum of 2 quarters · filed 2020-10-29 | $3.75M 10-Q · filed 2020-10-29 | $4.99M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.25M 10-Q · filed 2020-08-06 | $2.50M 10-Q · filed 2020-08-06 | $3.75M derived: sum of 3 quarters · filed 2021-02-25 | $3.75M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $1.25M 10-Q · filed 2020-04-30 | $2.50M derived: sum of 2 quarters · filed 2021-02-25 | $2.50M derived: sum of 3 quarters · filed 2021-02-25 | $2.50M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.25M derived: sum of 2 quarters · filed 2021-02-25 | $1.25M derived: sum of 3 quarters · filed 2021-02-25 | $1.25M 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 10-Q · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |